
    
      To assess the efficacy and tolerability of a new drug containing the combination meloxicam
      and cyclobenzaprine in the treatment of acute lumbago, compared to the same components alone.

      Some eligibility criteria:

      Have a normal X-ray of the lumbar spine for the age; Have a baseline score in the VAS higher
      than or equal to 40 mm
    
  